Mitomycin C-treated antigen-presenting cells as a tool for control of allograft rejection and autoimmunity: from bench to bedside.

MLA

Terness, Peter, et al. “Mitomycin C-Treated Antigen-Presenting Cells as a Tool for Control of Allograft Rejection and Autoimmunity: From Bench to Bedside.” Human Immunology, vol. 70, no. 7, July 2009, pp. 506–12. EBSCOhost, https://doi.org/10.1016/j.humimm.2009.04.024.

APA

Terness, P., Kleist, C., Simon, H., Sandra-Petrescu, F., Ehser, S., Chuang, J.-J., Mohr, E., Jiga, L., Greil, J., & Opelz, G. (2009). Mitomycin C-treated antigen-presenting cells as a tool for control of allograft rejection and autoimmunity: from bench to bedside. Human Immunology, 70(7), 506–512. https://doi.org/10.1016/j.humimm.2009.04.024

Chicago

Terness, Peter, Christian Kleist, Helmut Simon, Flavius Sandra-Petrescu, Sandra Ehser, Jing-Jing Chuang, Elisabeth Mohr, Lucian Jiga, Johann Greil, and Gerhard Opelz. 2009. “Mitomycin C-Treated Antigen-Presenting Cells as a Tool for Control of Allograft Rejection and Autoimmunity: From Bench to Bedside.” Human Immunology 70 (7): 506–12. doi:10.1016/j.humimm.2009.04.024.